NCT03305822View on ClinicalTrials.gov

A Study of LY900014 in Participants With Type 2 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

October 11, 2017

Primary Completion Date

December 14, 2017

Study Completion Date

December 14, 2017

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

LY900014

Administered SC

DRUG

Insulin Lispro

Administered SC

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Neuss

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03305822 - A Study of LY900014 in Participants With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter